| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
The Departments of Medicine and Physiology, Duke University Medical Center Durham, N.C.
* Department of Biochemistry, University of Arizona Medical College Tucson, Arizona
Reprints: Marc K. Drezner, M. D., Box M 3285, Duke University Medical Center, Durham, N.C. 27710.
Pseudohypoparathyroidism (PsH) is a genetic disease characterized by hypocalcemia, hyperphosphatemia, and metabolic unresponsiveness to parathyroid hormone (PTH). The administration of PTH elicits neither a significant rise in serum calcium (calcemic response) nor a decrease in the renal tubule reabsorption of phosphorus (phosphaturic response). The diminished phosphaturic response is due to an inability of PTH to generate cyclic AMP in renal tubule cells. We investigated the question of whether hypocalcemia and deficient calcemic response to PTH are due to a similar cyclic AMP defect in bone or to an acquired vitamin D deficiency. Four patients were studied. The active form of vitamin D (1,25-dihydroxycholecaIciferol) was measured in 3 and was low. Treatment with vitamin D2 restored the serum calcium and the calcemic response to PTH to normal without changing the impaired renal response. Bone biopsy was performed in 2 patients and showed morphologic evidence of increased osteoclastic activity and osteomalacia. The data indicate that the hypocalcemia and bone disease in PsH are due to active vitamin D deficiency, possibly resulting from the genetic renal lesion.
Received March 10, 1975.
This article has been cited by other articles:
 |
|
 |
|
  M. Bastepe and H. Juppner Pseudohypoparathyroidism, Gs{alpha}, and the GNAS Locus IBMS BoneKEy, December 1, 2005; 2(12): 20 - 32. [Full Text] [PDF]
|
|
|
|
 |
|
 L. S. Weinstein, S. Yu, D. R. Warner, and J. Liu Endocrine Manifestations of Stimulatory G Protein {alpha}-Subunit Mutations and the Role of Genomic Imprinting Endocr. Rev., October 1, 2001; 22(5): 675 - 705. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Vlaeminck-Guillem, M. D'herbomez, P. Pigny, A. Fayard, C. Bauters, M. Decoulx, and J.-L. Wemeau Pseudohypoparathyroidism Ia and Hypercalcitoninemia J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3091 - 3096. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Goji Normocalcemic Patient With Pseudohypoparathyroidism: Effect of Parathyroid Hormone and Dibutyryl Cyclic Adenosine 3', 5'-Monophosphate on 1,25-Dihydroxycholecalciferol Formation Arch Pediatr Adolesc Med, August 1, 1988; 142(8): 815 - 817. [Abstract] [PDF]
|
|
|
|
|
|
S. Dabbagh, R. W. Chesney, L. O. Langer, H. F. DeLuca, E. F. Gilbert, and J. H. DeWeerd Jr Renal-Nonresponsive, Bone-Responsive Pseudohypoparathyroidism: A Case With Normal Vitamin D Metabolite Levels and Clinical Features of Rickets Arch Pediatr Adolesc Med, November 1, 1984; 138(11): 1030 - 1033. [Abstract] [PDF]
|
|
|
|
 |
|
 G. L. KLEIN, R. L. HORST, A. W. NORMAN, M. E. AMENT, E. SLATOPOLSKY, and J. W. COBURN Reduced Serum Levels of I{alpha}, 25-Dihydroxyvitamin D During Long-term Total Parenteral Nutrition Ann Intern Med, May 1, 1981; 94(5): 638 - 643. [Abstract] [PDF]
|
|
|
|
|
|
A. CAVALLO, W. J. MEYER III, J. B. BODENSTEINER, J. B. BODENSTEINER, and A. L. CHESSON Spinal Cord Compression: An Unusual Manifestation of Pseudohypoparathyroidism Arch Pediatr Adolesc Med, July 1, 1980; 134(7): 706 - 707. [Abstract] [PDF]
|
|
|
|
|
|
R. J. POLLET and G. S. LEVEY Principles of Membrane Receptor Physiology and Their Application to Clinical Medicine Ann Intern Med, May 1, 1980; 92(5): 663 - 680. [Abstract] [PDF]
|
|
|
|
|
|
S. S. Gellis, M. Feingold, J. P. Farriaux, and G. Fontaine Picture of the Month Arch Pediatr Adolesc Med, July 1, 1977; 131(7): 807 - 808. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
